Side Effect of Drug Clinical Trial
Official title:
A Multi-gene Pharmacogenetic Panel to Prevent Adverse Drug Reactions in Daily Primary Care Practice: Open-label, Mayo Clinic Multisite (Mankato-Rochester Primary Care), Controlled, Implementation Study Taking the Results of the PREPARE Study Into Minnesota (PREPARE-Mayo)
The purpose of this study is to determine whether the implementation of pre-emptive pharmacogenomic (PGx) testing of a panel of clinically relevant PGx markers, to guide the dose and drug selection for 39 commonly prescribed drugs, will result in an overall reduction in the number of clinically relevant drug-genotype associated ADRs which are causally related to the initial drug of inclusion (referred to as 'index drug').
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04696445 -
Pharmacokinetics of Morphine and Oxycodone in Frail Elderly Undergoing Cardiac Surgery
|
||
Recruiting |
NCT01477242 -
The Effect of Ondansetron During Intramuscular Ketamine Use in Children: A Trial in Emergency Department
|
N/A | |
Recruiting |
NCT05775419 -
Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC
|
N/A | |
Completed |
NCT06035900 -
Evaluation of Safety, Rate and Extent of Absorption of Psilocin Mucate
|
Phase 1 | |
Completed |
NCT04475029 -
Methadone in Cystectomy Patients
|
N/A | |
Recruiting |
NCT03996941 -
Harm Reduction Program For Informal PrEP Users In A Community-based Setting (seguiPrEP)
|
||
Recruiting |
NCT04701151 -
NORTH-REG Dwell-Time Study
|
Phase 4 | |
Not yet recruiting |
NCT04644354 -
The Efficacy of Nifedipine in the Management of Preterm Labor
|
||
Completed |
NCT03183908 -
FLUAD® vs. Fluzone® High-Dose Study
|
Phase 4 |